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Objectives: To describe the aortic histopathologic substrates in patients with type A surgically 80 
treated acute aortic syndromes, to provide clinico-pathological correlations, and to identify the 81 
possible prognostic role of histology. 82 
Methods: We assessed the aortic wall degenerative and/or inflammatory alterations of 158 patients 83 
according to the histopathologic consensus documents. Moreover, we correlated these histologic 84 
patterns with the patients’ clinical data as well as long-term follow-up for mortality, major aorta-85 
related events, and non-aorta-related events (including cardiovascular ones).  86 
Results: We identified two histopathologic patterns: 122 (77%) patients with degenerative 87 
alterations and 36 (23%) with mixed degenerative-atherosclerotic lesions. Patients with mixed 88 
alterations were older (mean 69.6±8.7 vs. 62.2±12.4, p=0.001) and more hypercholesterolemic 89 
(33.3% vs. 13.9%, p=0.017). The degenerative subgroup showed more Intralamellar-Mucoid 90 
Extracellular Matrix Accumulation (86% vs. 66.7%, p=0.017), and a lower prevalence of 91 
Translamellar Collagen Increase  (9.8% vs. 50%, p<0.001). Patients with mixed degenerative- 92 
atherosclerotic abnormalities more frequently had long-term non-aorta-related events compared to 93 
those with degenerative abnormalities alone (p=0.046); no differences were found between the 94 
groups with respect to long term mortality, major aorta-related events and cardiovascular non-aorta-95 
related events. 96 
Conclusion: Although degenerative lesions of the medial layer were present in all specimens, 97 
substantial atherosclerosis coexisted in nearly a quarter of cases. Patients with mixed degenerative-98 
atherosclerotic abnormalities had a coherent clinical risk profile, a clinical presentation frequently 99 
mimicking ACS and a higher incidence of non-aorta-related events during follow-up. So, 100 
histopathologic characterization may improve the long-term prognostic stratification of patients 101 
following surgical treatment. 102 






Type A Acute Aortic Syndromes (AAS) are a life-threat ning condition that require emergency 106 
surgical treatment (1). Although different inherited and acquired conditions predispose to this 107 
dramatic event, our knowledge of the histology of the diseased aortic wall is incomplete. The 108 
available clinico-pathological correlation studies are relatively old and tend to examine acute and 109 
chronic aortic diseases together (2-5). 110 
The histopathology underlying type A AAS is generally considered due to degenerative lesions of 111 
the aortic medial layer, first identified by Ehrdheim in 1930 as “aortic idiopathic (cystic) medial 112 
necrosis” (6). Recently, however, the Association for European Crdiovascular Pathology (AECVP) 113 
and the Society for Cardiovascular Pathology (SCVP) have proposed a revised nomenclature, 114 
terminology, grading systems and diagnostic criteria for aortic diseases in two consensus statements 115 
on the histopathology of inflammatory (7) and non-inflammatory degenerative (8) aortic diseases. 116 
We applied these criteria to the analysis of the aortic specimens obtained during surgery, with the 117 
aim of providing detailed histopathologic characterization and search for clinico-pathological 118 




Clinical setting 123 
Our Hospital is the AAS referral centre for Bologna and the surrounding metropolitan area 124 
(catchment area 1000000 inhabitants).  125 
Our registry includes all adult (>18 years) consecutive patients with a final diagnosis of 126 
spontaneous AAS referred to our centre between January 1st 2000 and December 31st 2013. Patients 127 
with symptom onset >14 days or with traumatic AAS were not included. Median follow-up for 128 
alive patients was 4 years (interquartile range 2.2-6 years). The study conforms to the principles 129 
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outlined in the Declaration of Helsinki, was approved by the local ethics committee and patients 130 
provided written informed consent.  131 
132 
Pathology 133 
An average of six samples were obtained from ascending aortic specimens of patients operated for 134 
type A AAS and paraffin embedded (supplementary figure 1). The histologic sections were 135 
stained with Hematoxylin-Eosin and stainings for collagen (Azan-Mallory trichrome) and elastic 136 
fibres (Weigert-Van Gieson). 137 
The samples were evaluated de novo, blind to clinical data, applying the AECVP/SCVP documents 138 
diagnostic criteria (7, 8). 139 
Degenerative aortic medial damage was assessed as overall medial degeneration (MD) resulting 140 
from the sum of 6 individual abnormalities: mucoid extracellular matrix accumulation (MEMA), 141 
both intralamellar (I-MEMA) and translamellar (T-MEMA); elastic fibre fragmentation/loss 142 
(EFFL); elastic fibre thinning out (EFT); laminar medial collapse (LMC); intralamellar collagen 143 
increase (ICI) and translamellar collagen increase (TCI).  144 
Overall MD was graded as mild, moderate or severe, considering both severity and distribution of 145 
single abnormalities. 146 
Atherosclerotic plaques were described according to the American Heart Association (AHA) 147 
scheme (9, 10). Atherosclerosis was then graded as not significant, mild, moderate or severe. Only 148 
moderate to severe lesions were considered causative of significant medial damage.  149 
150 
Clinical definitions 151 
Major aorta-related events were defined as re-hospitalizations for the following aortic complications 152 
in some cases requiring re-intervention: organ malperfusion, increasing aortic diameter, progressive 153 
false lumen dilation, aortic rupture, re-dissection, moderate/severe aortic regurgitation.  154 
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Non-aorta-related events were defined as re-hospitalizations for other CV causes (including acute 155 
coronary syndrome (ACS), congestive heart failure, arrhythmia, cerebrovascular accident, bleeding, 156 
and other CV causes) and re-hospitalization for non-CV causes, mainly neoplasms and infections.  157 
Sudden death was considered aorta-related in cases of aortic rupture documented on post-mortem or 158 
when preceded by signs or symptoms suggestive of cardiac tamponade or aneurysm rupture. 159 
Sudden death was considered cardiac, but not aorta-related in the remaining cases.  160 
High CV risk included patients with history of coronary artery disease and/or stroke and/or aged 161 
>40 with at least one CV risk factor (hypertension, hypercholesterolemia, diabetes, current smoking162 
habit).   163 
ACS-like ECG abnormalities were defined as previously described (11-12).  164 
Glomerular Filtration Rate (GFR) was estimated using the modified MDRD equation (13).  165 
Cardiac Troponin was measured with a standard assay up to 2010, and with a high-sensitivity assay 166 
thereafter.  167 
168 
Statistical analysis 169 
Categorical variables are expressed as number and percentage; continuous variables as mean ± 170 
standard deviation (SD) or median and interquartile range (IQR). Categorical variables were 171 
compared with Chi-square test or Fisher exact test in cases of small number of events. Shapiro-Wilk 172 
W test was performed to assess normality distribution of continuous variables; then comparisons 173 
were performed with Student's t-test or Mann-Whitney test accordingly. The Kaplan Meier method 174 
was used to analyse the occurrence of death (Log-rank test for curves comparison); Cox regression 175 
analysis was performed to identify predictors of mortality. Major aorta-related events, CV and other 176 
non-aorta-related events were evaluated with cumulative incidence function with death as 177 
competing risk (Pepe and Mori test for curves comparison), and competing risk regressions were 178 
used to identify long-term predictors. Regarding Cox regression model, proportional-hazards 179 
assumption was evaluated on the basis of Schoenfeld residuals. For other events (aorta-related, non-180 
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aorta-related, CV non-aorta-related) the proportional-subhazards assumption in competing risk 181 
regression was tested ensuring that coefficients were time invariant. All variables tested at the 182 
univariable analysis were included in the initial multivariable model, one-by-one tested and 183 
eventually excluded according to p and chi squared values of the subsequent models. All statistical 184 
analyses were performed using Stata/SE 14.2 (StataCorp LP, College Station, Texas, USA). A p 185 
value <0.05 was considered significant. 186 
187 
RESULTS 188 
Study population and histopathologic findings 189 
257 patients with type A AAS were considered; 218 (85%) underwent surgical treatment during the 190 
index hospitalization. Surgical specimens for histology were available for 158 patients who 191 
constituted our study population (supplementary figure 2). Baseline histopathologic characteristics 192 
are reported in Table 1. Patients with unavailable aortic specimens (60) had similar baseline 193 
characteristics to those included in the study (supplementary table 1). All surgical specimens 194 
showed MD and this was severe in 38 patients (24%). The most frequent degenerative 195 
abnormalities were EFFL (153 patients, 98.7%) and EFT (145 patients, 92.8%), and I-MEMA (129 196 
patients, 81.6%), (figure 1). Coexisting atherosclerosis (any grade) was documented in 88 patients 197 
(55.7%), and was moderate or severe in 36 (22.8%). Patients with coexisting moderate-severe 198 
atherosclerosis constituted the mixed degenerative-atherosclerotic group, renamed "mixed" for 199 
simplicity. The study population was therefore divided accordingly into two groups: 122 patients 200 
(77.2%) with exclusively degenerative abnormalities and 36 patients (22.8%) with mixed 201 
degenerative-atherosclerotic findings (figure 2).  202 
Comparing the two groups, MEMA - especially intralamellar - was the single abnormality 203 
that most characterized the degenerative group; the most frequent alteration in the mixed group was 204 
TCI. LMC was found in 61 patients (50%) in the degenerative group and in 14 (38.9%) in the 205 
mixed group. Among the mixed group, this abnormality was mainly (13/14) present as a dense band 206 
ACCEPTED MANUSCRIPT
9 
of elastic fibre compaction bordering the lower margin of atherosclerotic plaque. In degenerative 207 
patients on the other hand, LMC was usually found in the central areas of the medial layer above or 208 
on the same level as the dissection (supplementary figure 3). 209 
Clinical findings 210 
Baseline clinical characteristics of the study population are reported in table 2. 147 patients (93%) 211 
were diagnosed with acute aortic dissection, and the remaining 11 patients (7%) with intramural 212 
haematoma. Mean age was 63.9 and 68% were males. Amongst CV risk factors, hypertension was 213 
the most prevalent (114 patients, 72.2%), history of coronary artery disease (CAD) and stroke were 214 
present in 11 (7%) and in 5 patients (3.2%) respectively. Marfan syndrome (MFS) and bicuspid 215 
aortic valve coexisted in 2 (1.3%) and in 6 patients (3.8%) respectively.  216 
217 
Clinico-pathological correlations 218 
Mixed group patients were older (69.6 ± 8.7 vs. 62.2 ± 12.4, p=0.001) and had a higher prevalence 219 
of hypercholesterolemia compared to those in the degenerative group (33.3% vs. 13.9%, p=0.017). 220 
Additionally, clinical presentation of patients in the mixed group was more often characterised by 221 
chest pain and ACS-like ECG abnormalities (38.9% vs. 19.7%, p=0.032) (table 2).  222 
The comparison between patients with dissection (147) vs intramural haematoma (IMH, 10) did not 223 
show differences in the histopathologic diagnostic category. However, patients with dissection 224 
presented a higher percentage of T-MEMA (70.7% vs 36,4%, p=0.001) while IMH was strongly 225 
associated with atherosclerotic lesions (90.9% vs 53.1%, p=0.023) (supplementary table 2). 226 
Both patients with a diagnosis of MFS were included in the degenerative group with severe MD in 227 
one case and moderate MD in the other. No atherosclerosis was found in these patients.  228 
Of the 6 patients with bicuspid aortic valve, 5 had purely degenerative abnormalities - moderate in 229 
three cases, while it was graded mild and severe in the other two patients - while mixed 230 




Patients with ascending aorta diameter ≥55 mm at presentation had a more severe overall MD 232 
compared to patients with diameter <55 mm [51.7% (15/29) vs. 12.3% (7/57), p<0.001], showing 233 
mostly moderate/severe I-MEMA, T-MEMA and EFT (supplementary table 3).  234 
Patients over the age of 50 were more frequently found to have atherosclerotic abnormalities 235 
[59.8% (82/137) vs. 28.6% (6/21), p=0.014], I-MEMA [83,2% (114/137) vs. 71.4% (15/21), 236 
p=0.006], and moderate/severe EFFL [81.7% (112/137) vs. 23.8% (5/21), p<0.001] 237 
(supplementary table 4). 238 
Figure 3 shows the prevalence of atherosclerosis according to age, gender, ascending aorta 239 
diameter and AAS subtype according to the DeBakey classification.  240 
 241 
Outcome and prognostic stratification 242 
In-hospital mortality reached 19% (30 patients) in our population. 45 patients died during follow-243 
up, with an all-cause mortality at 1, 3 and 6-years of 23%, 26% and 33% respectively. The cause of 244 
death was aorta-related in 22 patients (post-operativ  complications in 21 cases, one patient died 245 
after reintervention for severe aortic regurgitation during follow-up), CV non-aorta-related in 8 246 
patients (1 for ischemic strokes, 3 for haemorrhagic strokes, 2 for endocarditis on prosthetic valve, 1 247 
for sudden cardiac death and 1 for cardiogenic shock se ondary to ischemic dilated cardiopathy), 248 
and non-CV-related in 15 patients (cancer in 4, sepsi  in 8, and other causes in 3).  249 
Cumulative incidence of major aorta-related events at 1, 3 and 6-years follow-up was 9%, 16% and 250 
25% respectively, that of non aorta-related events wa 31%, 44% and 64% respectively, and that of 251 
CV non-aorta-related events was 10%, 17% and 23% respectively.  252 
Figure 4 and figure 5 show the 6-year clinical outcome according to histopa hologic 253 
characteristics. Patients with mixed degenerative-ath rosclerotic abnormalities more frequently had 254 
non-aorta-related events during follow-up compared to those with degenerative abnormalities alone 255 
(Pepe and Mori test, p=0.046, figure 5). No differences were found between these two subgroups 256 
with respect to mortality (34 deaths among degenerativ  patients and 11 among mixed patients at 257 
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the end of follow-up, log-rank test, p=0.574), major aorta-related events (19 events among 258 
degenerative patients and 10 events among mixed patients at the end of follow-up, Pepe and Mori 259 
test, p=0.407), and CV non-aorta-related events (19 events among degenerative patients and 10 260 
events among mixed patients at the end of follow-up, Pepe and Mori test, p=0.202).  261 
Table 3A and table 3B report the major clinical and histologic incremental risk factors for 262 
6-year-mortality and for 6-year-non-aorta-related events. Age [HR 1.03 for each 1-year increase;263 
95% CI 0.99-1.06; P=0.069, borderline significance] and GFR < 60 ml/min/1.73m2 at presentation 264 
[HR 2.33; 95% CI 1.24-4.4; P=0.009] were independent predictors of mortality (t ble 3A). Non-265 
aorta-related events were analysed in detail, and no differences were found according to the 266 
patients’ CV risk profile (supplementary figure 4). Hypertension [SHR 1.79; 95% CI 1.01-3.21; 267 
P=0.047] and the coexistence of atherosclerotic lesions together with degenerative abnormalities 268 
[SHR 1.65; 95% CI 0.96-2.84; P=0.068, borderline significance] were found to be independent risk 269 
predictors for non-aorta-related events (table 3B). 270 
271 
DISCUSSION 272 
This is the first study that provides a detailed description of the histopathologic findings of 273 
aortic specimens - as well as their clinico-pathological correlation - from a large unselected cohort 274 
of patients with type A AAS, applying the classification and diagnostic criteria from the recent 275 
AECVP/SCVP consensus statements (7, 8). The main findings of the study are: 1. Although 276 
degenerative lesions of the medial layer were present in all specimens, substantial atherosclerosis 277 
coexisted in nearly a quarter; 2. Patients with mixed degenerative-atherosclerotic abnormalities had 278 
a coherent clinical risk profile, with a more frequent presentation mimicking ACS and a long-term 279 
follow-up characterized by non-aorta-related events, including coronary and cerebrovascular events; 280 
3. Histopathologic characterization could help the long-term prognostic stratification of patients281 




 The histopathologic substrate of our cohort was heterogeneous do to the variable 283 
combination – quantitatively and qualitatily - of degenerative and atherosclerotic lesions. All 284 
patients showed MD abnormalities: almost all cases had elastic fibre abnormalities, including both 285 
thinning out and fragmentation; MEMA was present as I-MEMA in over 80% of patients and as T-286 
MEMA (an expression of a more severe mucopolysaccharide accumulation) in 68.4%; collagen 287 
increase was present with a heterogeneous distribution: intralamellar in 74% and translamellar (i.e. 288 
fibrosis) in 19% of cases. It is noteworthy that more than 50% of patients had some degree of 289 
atherosclerosis associated with degenerative lesions. Almost a quarter had moderate/severe 290 
atherosclerosis, which the AECVP/SCVP statement (7) considers a cause of significant aortic wall 291 
damage with consequent weakness.  292 
 The comparison between exclusively degenerative or mixed subgroups reveals differences 293 
in the distribution of mucoid accumulation and of fibrosis. I-MEMA was the most typical lesion in 294 
purely degenerative patients, while translamellar collagen was distinctly increased in the mixed 295 
group. Interestingly, 1/3 of major atherosclerotic plaques was accompanied by a thick band of 296 
medial laminar collapse, which, together with TCI, can probably be considered a final response to 297 
the atherosclerotic plaque penetrating more deeply into the media. Elastic fibre alterations were 298 
present in the purely degenerative and mixed groups in equal measure, probably due to the 299 
heterogeneity of various causative conditions, including the aging process. Our only 2 patients with 300 
Marfan syndrome and five out of six patients with bicuspid aortic valve had moderate/severe 301 
degenerative lesions, in line with the findings of previous studies (14, 15). 302 
 Unlike previously published similar series (2-5), our study included exclusively patients 303 
with AAS. The first two published series evaluating clinico-pathological features of the ascending 304 
aorta described 63 (2) and 339 patients (3) who underwent surgery for aneurysm or dissection of the 305 
ascending aorta. Compared to our population, the patients in these series were younger, with a 306 
higher prevalence of connective tissue disorders and a lower prevalence of severe atherosclerosis. 307 




of MD and age was found (3). A more recent study describing 513 patients (4) found that 309 
connective tissue disorders were most frequently associated with MD, followed by aging and no 310 
association between bicuspid aortic valve and medial egeneration was found. Severe 311 
atherosclerosis was described in an exiguous number of patients. Again, it should be noted that the 312 
population in this series was younger compared to ours and that both aneurysms and dissections 313 
were considered. A further study on 338 surgical specimens including a few Marfan patients, found 314 
that MD was a common, age-related and non-specific histological pattern in aortic aneurysms and 315 
dissections (5). Atherosclerosis was present only in 10% of patients, and was more frequently 316 
associated with aneurysms than dissections.  317 
 In our study atherosclerosis was more frequent than previously described, and this is 318 
probably due to the older age of our patients. On the other hand, clinical and epidemiological 319 
characteristics of our study population were similar to those of the largest “real world registry” 320 
IRAD (International Registry of Acute Aortic Dissection) (16).  In particular, mean age (63.9 321 
years), prevalence of male gender (about 68.4%), hypertension (72.2%) and bicuspid aortic valve 322 
(3.8%) were quite similar whereas Marfan syndrome was less frequent (1.3% vs. 4.7%) probably 323 
due to the prophylactic surgery strategy adopted in our network.   324 
 As expected, patients with atherosclerotic lesions had a higher CV risk profile: in 325 
particular, they were older, male, and hypercholesterolemic. Interestingly, atherosclerotic lesions 326 
were more frequent in patients with a diameter of the ascending aorta <55 mm, and in type I AAS 327 
compared with type II (borderline significance) (figure 3). 328 
 The long-term outcome of patients with associated therosclerosis is characterized by high 329 
probability of non-aorta related events including coronary and cerebrovascular events and infectious 330 
complications even if no association with overall mortality was shown. As already demonstrated by 331 
other studies, renal function and age (borderline sgnificance in our work) were found to be risk 332 
factors for mortality (17). Notably, along with hypertension, the presence of atherosclerotic 333 




the histopathologic substrate underlying AAS may provide additional information to the level of 335 
risk derived from patients’ clinical characteristic alone. 336 
 337 
Study limitations 338 
 Due the monocentric nature of our work, the size of the study population and relative 339 
events are not comparable with international registries. Twenty-seven percent of aortic specimens 340 
among surgically treated patients did not reach the histology laboratory due to logistic reasons.   341 
Marfan syndrome was less frequent in our study than in other series probably due to the 342 
prophylactic surgery strategy adopted in our network.  343 
Whereas the description of the histopathologic spectrum - according to the current AECVP/SCVP 344 
classification - in patients with type A AAS provides robust and new information, the impact of 345 
clinico-pathological correlations is inevitably limited by the relatively small study population and 346 
the few events during follow-up. Lastly, due to the retrospective nature of this study and the 347 
emergency clinical setting, availability of laboratory data and imaging details - both at presentation 348 
and during follow-up - is limited.  349 
 350 
Clinical implications 351 
The new AECVP/SCVP classification allows a comprehensive description of aortic wall 352 
abnormalities, provides a standardised characterizaion of MD, and represents a useful tool for 353 
nosography, clinico-pathological correlations, and prognostic information in patients with type A 354 
AAS. Full knowledge of the histopathologic details of patients who underwent surgery for AAS can 355 
lead to better planning of long-term follow-up, espcially regarding preventive strategies for non-356 
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FIGURE LEGENDS 416 
Figure 1 Microscopic images illustrating the most frequently found degenerative lesions. A-B: 417 
Aortic dissection in a Marfan patient showing severe elastic fibre fragmentation/loss around the 418 
false lumen (arrows) (A, Weigert Van Gieson, original magnification x25); detail of elastic fibre 419 
fragmentation (arrows) (B, Weigert Van Gieson, original magnification x100). C-D: Full thickness 420 
aortic specimen with an area of elastic fibre rarefaction in the outer medial layer (C, arrow: Weigert 421 
Van Gieson, original magnification x25); the detail shows thinning out of elastic fibres and enlarged 422 
spaces between them (D: Weigert Van Gieson, original magnification x400). E-F: Examples of 423 
intralamellar-mucoid extracellular matrix accumulation: there is mild (E, x100) to moderate (B, 424 
x200) enlargement of intralamellar spaces containing bluish-pink mucoid material (Haematoxylin-425 
Eosin stain).   426 
Figure 2 A-B: Aortic dissection samples from pure degenerative patients. A: 45 year-old male with 427 
mild medial degeneration (Haematoxylin-Eosin, original magnification x25); B: 25 year-old male 428 
with bicuspid aortic valve and severe medial degeneration (B, Weigert Van Gieson stain, original 429 
magnification x25). C-D: Aortic specimens from the mixed group. The dissection is above the 430 
atherosclerotic lesions and the underlying media shows multifocal elastic fibre fragmentation (C 431 
arrows) and translamellar (D, arrow) collagen increase (Azan Mallory trichrome, original 432 
magnification x25).  433 
Figure 3 Prevalence of atherosclerotic lesions according to age, ascending aorta diameter, gender, 434 
and De Bakey subtype. 435 
Figure 4 Mortality (left) and major aorta-related events (right) of type A AAS patients with 436 
degenerative (122 patients, green line) versus mixed (36 patients, blue line) histological 437 
abnormalities. 438 
Figure 5 Non-aorta-related events (left) and cardiovascular non-aorta-related events (right) of type 439 
A AAS patients with degenerative (122 patients, green line) versus mixed (36 patients, blue line) 440 













Atherosclerosis 88 (55.7%) 52 (42.6%) 36 (100%) NA 
Severe 8 (5.1%) 0 (0%) 8 (22.2%) NA 
Moderate 28 (17.7%) 0 (0%) 28 (77.8%) NA 
Mild 52 (32.9%) 52 (42.6%) 0 (0%) NA 
Not significant 70 (44.3%) 70 (57.4%) 0 (0%) NA 
Degenerative lesions 158 (100%) 122 (100%) 36 (100%) 1 
I-MEMA 129 (81.6%) 105 (86%) 24 (66.7%) 0.017 
Moderate/severe I-MEMA 93 (58.9%) 80 (65.6%) 13 (36.1%) 0.002 
T-MEMA 108 (68.4%) 88 (72.1%) 20 (55.6%) 0.094 
Moderate/severe T-MEMA 108 (68.4%) 88 (72.1%) 20 (55.6%) 0.094 
Laminar medial collapse 75 (47.5%) 61 (50%) 14 (38.9%) 0.325 
Dense laminar medial collapse 59 (37.3%) 46 (37.7%) 13 (36.1%) 0.982 
Elastic fibre thinning out 145 (92.8%) 115 (94.3%) 30 (83.3%) 0.08 
Moderate/severe elastic fibre 
thinning out 
108 (68.4%) 87 (71.3%) 21 (58.3%) 0.205 
Elastic fibre fragmentation 153 (98.7%) 117 (95.9%) 36 (100%) 0.489 
Moderate/severe elastic fibre 
fragmentation 
117 (74%) 91 (74.6%) 26 (72.2%) 0.945 
Intralamellar collagen increase 117 (74%) 93 (76.2%) 24 (66.7%) 0.35 





Translamellar collagen increase 30 (19%) 12 (9.8%) 18 (50%) < 0.001 
Moderate/severe translamellar 
collagen increase 
18 (11.4%) 5 (4%) 13 (36.1%) < 0.001 
Overall severe degenerative 38 (24%) 32 (26.2%) 6 (16.7%) 0.274 
AAS: Acute Aortic Syndrome; I-MEMA: Intralamellar-Mucoid Extracellular Matrix Accumulation; 445 


































Aortic dissection  147 (93%) 115 (94.3%) 32 (88.9%) 0.459 
Intramural haematoma  11 (7%) 7 (5.7%) 4 (11.1%) 0.273 
Plaque rupture-ulceration  0 (0%) 0 (0%) 0 (0%) 1 
De Bakey type I 111 (70.3%) 89 (73%) 22 (61.1%) 0.247 
Patients’ characteristics 
Age (years), mean ± SD 63.9 ± 12 62.2 ± 12.4 69.6 ± 8.7 0.001 
Male gender 108 (68.4%) 80 (65.6%) 28 (77.8%) 0.238 
Hypertension (history) 114 (72.2%) 84 (68.9%) 30 (83.3%) 0.136 
Hypercholesterolemia 29 (18.4%) 17 (13.9%) 12 (33.3%) 0.017 
Diabetes  6 (3.8%) 6 (4.9%) 0 (0%) 0.337 
Current smoke 31 (19.6%) 23 (18.9%) 8 (22.2%) 0.639 
Marfan syndrome 2 (1.3%) 2 (1.6%) 0 (0%) 1 
Bicuspid aortic valve  6 (3.8%) 5 (4.1%) 1 (2.8%) 1 
Aortic coarctation 0 (0%) 0 (0%) 0 (0%) 1 
Known thoracic-abdominal aortic 
aneurysm (surgically treated or not) 
13 (8.2%) 8 (6.6%) 5 (13.9%) 0.174 
Previous AAS 2 (1.3%) 1 (0.8%) 1 (2.8%) 0.404 
Previous stroke 5 (3.2%) 4 (3.3%) 1 (2.8%) 1 
Coronary artery disease (history) 11 (7%) 6 (4.9%) 5 (13.9%) 0.127 
Clinical features at presentation 
Systolic blood pressure (mmHg), 
mean ± SD 




Back pain 56 (35.4%) 42 (34.4%) 14 (38.9%) 0.769 
Chest pain  117 (74.1%) 88 (72.1%) 29 (80.6%) 0.426 
Migratory pain  16 (10.1%) 10 (8.2%) 6 (16.7%) 0.203 
Abdominal pain 35 (22.2%) 27 (22.1%) 8 (22.2%) 1 
CVA at presentation 5 (3.2%) 5 (4.1%) 0 (0%) 0.589 
Peripheral pulse deficit 36 (22.3%) 25 (20.5%) 11 (30.6%) 0.257 
Shock within 12h of admission 28 (14.3%) 24 (19.7%) 4 (11.1%) 0.322 
ACS-like ECG+chest pain 38 (24.1%) 24 (19.7%) 14 (38.9%) 0.032 
ACS-like ECG 48 (30.4%) 32 (26.2%) 16 (44.4%) 0.06 
Aortic diameters (mm) on imaging at presentation 
































Laboratory findings  






















Pericardial effusion 64 (40.5%) 49 (40.2%) 15 (41.7%) 0.975 
Periaortic effusion 13 (8.2%) 8 (6.6%) 5 (13.9%) 0.174 
Moderate/severe aortic 
regurgitation 
61 (38.6%) 44 (36.1%) 17 (47.2%) 0.311 
Cardiac tamponade 19 (12%) 15 (12.3%) 4 (11.1%) 1 
Coronary ostia involvement 16 (10.1%) 12 (9.8%) 4 (11.1%) 0.761 
AAS: Acute Aortic Syndrome; ACS: Acute Coronary Syndrome; CT: Computed Tomography; 467 
CVA: Cerebrovascular Accident; GFR: Glomerular Filtration Rate; SD: Standard Deviation; IQR: 468 

























HR (95% CI) P value HR (95% CI) P value 
Age (for each 1-year increase) 1.03 (1.01-1.06) 0.019 1.03 (0.99-1.06) 0.069 
Male gender 0.95 (0.51-1.78) 0.897 
Hypertension (history) 1.16 (0.59-2.31) 0.653 
Hypercholesterolemia 1.22 (0.58-2.54) 0.587 
Diabetes 2.03 (0.62-6.59) 0.237 
Current smoke 0.67 (0.28-1.58) 0.365 
Marfan-BAV 0.33 (0.04-2.46) 0.285 
De Bakey type I 1.9 (0.47-1.71) 0.75 
GFR < 60 ml/min/1.73m2 at 
presentation 
2.66 (1.43-4.95) 0.002 2.33 (1.24-4.40) 0.009 
Degenerative-atherosclerotic 
lesions 
1.07 (0.54-2.11) 0.839 
Atherosclerosis (for each 1-point 
increase according to AHA 
classification) 
1.12 (0.98-1.29) 0.083 
Harrell’s C=0.65; Goodness of fit test (score test)=0.553; AIC=382; BIC=388 488 
AAS: Acute Aortic Syndrome; AHA: American Heart Association; BAV: Bicuspid Aortic Valve; 489 















 SHR (95% CI) P value SHR (95% CI) P value 
Age (for each 1-year increase) 1.01 (0.98-1.03) 0.426   
Male gender 0.87 (0.54-1.44) 0.611   
Hypertension (history) 1.94 (1.09-3.46) 0.023 1.79 (1.01-3.21) 0.047 
Hypercholesterolemia 0.97 (0.49-1.94) 0.954   
Diabetes 0.32 (0.03-2.82) 0.309   
Current smoke 0.86 (0.45-1.64) 0.651   
Marfan-BAV 0.69 (0.25-1.88) 0.472   
De Bakey type I 0.84 (0.51-1.42) 0.534   
GFR < 60 ml/min/1.73m2 at 
presentation 
0.67 (0.39-1.15) 0.151   
Degenerative-atherosclerotic 
lesions 
1.83 (1.09-3.07) 0.022 1.65 (0.96-2.84) 0.068 
Atherosclerosis (for each 1-point 
increase according to AHA 
classification) 
1.06 (0.95-1.18) 0.245   
AIC=585.9; BIC 592.1 496 
AAS: Acute Aortic Syndrome; AHA: American Heart Association; BAV: Bicuspid Aortic Valve; 497 








SUPPLEMENTARY FILES 503 
 504 
Supplementary table 1 Type A AAS surgically treated patients with available versus unavailable 505 

















Aortic dissection  198 (90.8%) 147 (93%) 51 (85%) 0.116  
Intramural haematoma  18 (8.3%) 11 (7%) 7 (11.7%) 0.276  
Plaque rupture-ulceration  2 (0.9%) 0 (0%) 2 (3.3%) 0.074  
De Bakey type I 147 (67.4%) 111 (70.3%) 36 (60%) 0.2  
Patients’ characteristics  
Age (years), mean ± SD 64.4 ± 12.1 63.9 ± 12 65.5 ± 12.4 0.385  
Men 148 (67.9%) 108 (68.4%) 40 (66.7%) 0.939  
Hypertension (history) 157 (72%) 114 (72.2%) 43 (71.7%) 0.922  
Hypercholesterolemia 43 (19.7%) 29 (18.4%) 14 (23.3%) 0.526  
Diabetes  9 (4.1%) 6 (3.8%) 3 (5%) 0.709  
Current smoke 37 (17%) 31 (19.6%) 6 (10%) 0.107  
Marfan syndrome 3 (1.4%) 2 (1.3%) 1 (1.7%) 1  
Bicuspid aortic valve  7 (3.2%) 6 (3.8%) 1 (1.7%) 0.676  
Aortic coarctation 0 (0%) 0 (0%) 0 (0%) 1  
Known thoracic-abdominal aortic 
aneurysm (surgically treated or not) 
19 (8.7%) 13 (8.2%) 6 (10%) 0.788 
 
Previous AAS 3 (1.4%) 2 (1.3%) 1 (1.7%) 1  
Previous stroke 9 (4.1%) 5 (3.2%) 4 (6.7%) 0.263  
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Coronary artery disease (history) 15 (6.9%) 11 (7%) 4 (6.7%) 01 
Clinical features at presentation 
Systolic blood pressure (mmHg), 
mean ± SD 
134.7 ± 38.4 134.5 ± 37.3 135.1 ± 41.9 0.932 
Back pain 81 (37.2%) 56 (35.4%) 25 (41.7%) 0.489 
Chest pain 161 (73.9%) 117 (74.1%) 44 (73.3%) 0.948 
Migratory pain 24 (11%) 16 (10.1%) 8 (13.3%) 0.477 
Abdominal pain 48 (22%) 35 (22.2%) 13 (21.7%) 0.916 
CVA at presentation 9 (4.1%) 5 (3.2%) 4 (6.7%) 0.263 
Peripheral pulse deficit 48 (22%) 36 (22.3%) 12 (20%) 0.975 
Shock within 12 of admission 39 (17.9%) 28 (14.3%) 11 (18.3%) 0.926 
ACS-like ECG+chest pain 50 (22.9%) 38 (24.1%) 12 (20%) 0.649 
ACS-like electrocardiogram 62 (28.4%) 48 (30.4%) 14 (23.3%) 0.389 
Aortic diameters (mm) in first imaging examination 
Valsalva sinuses, median (IQR) 







Ascending aorta, median (IQR) 
 50 (46-55) 
 (123/218) 
 51 (46-56) 
 (86/158) 
 50 (46-54) 
 (37/60) 
0.454 
Aortic arch, median (IQR) 
 34 (31-40) 
(42/218) 
 32 (31-39) 
 (27/158) 
 37 (34-41) 
 (15/60) 
0.253 
Descending aorta, median (IQR) 
 35 (29-41) 
(49/218) 
 32 (27-38) 
 (29/158) 
 40 (31-50) 
 (20/60) 
0.059 
Laboratory findings  
GFR (ml/min/1.73m2), median (IQR) 
 67 (54-81) 
(195/218) 

















Disease complications  
Pleural effusion 37 (17%) 25 (15.8%) 12 (20%) 0.595  
Pericardial effusion 89 (40.8%) 64 (40.5%) 25 (41.7%) 0.999  
Periaortic effusion 26 (11.9%) 13 (8.2%) 13 (21.7%) 0.012  
Moderate/severe aortic regurgitation 86 (39.4%) 61 (38.6%) 25 (41.7%) 0.797  
Cardiac tamponade 28 (12.8%) 19 (12%) 9 (15%) 0.651  
Coronary ostia involvement 21 (9.6%) 16 (10.1%) 5 (8.3%) 0.801  
AAS: Acute Aortic Syndrome; ACS: Acute Coronary Syndrome; CT: Computed Tomography; 507 
CVA: Cerebrovascular Accident; GFR: Glomerular Filtration Rate; SD: Standard Deviation; IQR: 508 






































Atherosclerosis 88 (55.7%) 78 (53.1%) 10 (90.9%) 0.023 
Severe 8 (5.1%) 6 (4.1%) 2 (18.2%) 0.098 
Moderate  28 (17.7%) 26 (17.7%) 2 (18.2%) 1 
Mild 52 (32.9%) 46 (31.3%) 6 (54.5%) 0.179 
Not significant 70 (44.3%) 
 
69 (46.9%) 1 (9.1%) 0.023 
Degenerative lesions 158 (100%) 147 (100%) 11 (100%) NA 
I-MEMA 129 (81.6%) 121 (82.3%) 8 (72.7%) 0.425 
Moderate/severe I-MEMA 93 (58.9%) 90 (61.2%) 3 (27.3%) 0.051 
T-MEMA 108 (68.4%) 104 (70.7%) 4 (36.4%) 0.001 
Moderate/severe T-MEMA 108 (68.4%) 104 (70.7%) 4 (36.4%) 0.001 
Laminar collapse 75 (47.5%) 69 (46.9%) 6 (54.5%) 0.757 
Dense laminar collapse 59 (37.3%) 54 (36.7%) 5 (45.4%) 0.747 
Elastic fibre thinning out 145 (92.8%) 134 (91.2%) 11 (100%) 0.601 
Moderate/severe elastic fibre 
thinning out 
108 (68.4%) 102 (69.4%) 6 (54.5%) 0.326 
Elastic fibre fragmentation 153 (98.7%) 143 (97.3%) 10 (90.9%) 0.306 
Moderate/severe elastic fibre 
fragmentation 
117 (74%) 110 (74.8%) 7 (63.6%) 0.477 
Intralamellar collagen 
increase 
117 (74%) 107 (72.8%) 10 (90.9%) 0.291 
Moderate/severe intralamellar 
collagen increase 
23 (14.6%) 19 (12.9%) 4 (36.4%) 0.056 
Translamellar collagen 
increase 
30 (19%) 27 (18.4%) 3 (27.3%) 0.438 
Moderate/severe translamellar 
collagen increase 
18 (11.4%) 16 (10.9%) 2 (18.2%) 0.363 
Degenerative group 122 (77.2%) 115 (78.2%) 7 (63.6%) 0.274 
Mixed group 36 (22.8%) 32 (21.8%) 4 (36.4%) 0.274 
Overall severe degenerative 38 (24%) 36 (24.5%) 2 (18.2%) 1 
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AAS: Acute Aortic Syndrome; NA: Not Applicable; I-MEMA: Intralamellar-Mucoid Extracellular 525 




































AORTA ≥ 55 mm 
(n=29, 33.7%) 
ASCENDING 





Atherosclerosis 45 (52.3%) 15 (51.7%) 30 (52.5%) 0.882 
Severe  6 (7%) 2 (6.9%) 4 (7%) 1 
Moderate  18 (20.9%) 5 (17.2%) 13 (22.8%) 0.779 
Mild  21 (24.4%) 8 (27.6%) 13 (22.8%) 0.791 
Not significant 41 (47.7%) 14 (48.3%) 27 (47.4%) 0.882 
Degenerative lesions 86 (100%) 29 (100%) 57 (100%) 1 
I-MEMA 62 (72.1%) 24 (82.8%) 38 (66.7%) 0.187 
Moderate/severe I-MEMA 40 (46.5%) 19 (65.5%) 21 (36.8%) 0.022 
T-MEMA 51 (59.3%) 23 (79.3%) 28 (49.1%) 0.014 
Moderate/severe T-MEMA 51 (59.3%) 23 (79.3%) 28 (49.1%) 0.014 
Laminar medial collapse 29 (33.7%) 12 (41.4%) 17 (29.8%) 0.406 
Dense laminar medial collapse 25 (29.1%) 11 (37.9%) 14 (24.6%) 0.298 
Elastic fibre thinning out 77 (89.5%) 26 (89.7%) 51 (89.5%) 0.729 
Moderate/severe elastic fibre 
thinning out 
26 (30.2%) 22 (75.9%) 4 (7%) <0.001 
Elastic fibre fragmentation 82 (95.3%) 29 (100%) 53 (9 %) 0.358 
Moderate/severe elastic fibre 
fragmentation 
57 (66.3%) 23 (79.3%) 34 (59.6%) 0.114 
Intralamellar collagen increase 62 (72.1%) 23 (79.3%) 39 (68.4%) 0.418 





Translamellar collagen increase 16 (18.6%) 5 (17.2%) 11 (19.3%) 1 
Moderate-severe translamellar 
collagen increase 
10 (11.6%) 3 (10.3%) 7 (12.3%) 1 
Degenerative group 62 (72.1%) 22 (75.9%) 40 (70.2%) 0.763 
Mixed group 24 (27.9%) 7 (24.1%) 17 (29.8%) 0.622 
Overall severe degenerative 21 (24.4%) 15 (51.7%) 7 (12.3%) <0.001 
AAS: Acute Aortic Syndrome; I-MEMA: Intralamellar-Mucoid Extracellular Matrix Accumulation; 553 




















Supplementary table 4 Histopathologic findings in patients aged > 50 years versus patients aged ≤ 571 






AGE > 50 YEARS 
(n=137, 86.7%) 




Atherosclerosis     
Severe  8 (5.1%) 8 (5.8%) 0 (0%) 0.598 
Moderate  28 (17.7%) 27 (19.7%) 1 (4.8%) 0.127 
Mild  52 (32.9%) 47 (34.3%) 5 (23.8%) 0.457 
Not significant 70 (44.3%) 55 (40.1%) 15 (71.4%) 0.014 
- Degenerative lesions 
I-MEMA 129 (81.6%) 114 (83.2%) 15 (71.4%) 0.006 
Moderate/severe I-MEMA 93 (58.9%) 81 (59.1%) 12 (57.1%) 1 
T-MEMA 108 (68.4%) 91 (66.4%) 17 (80.9%) 0.184 
Moderate/severe T-MEMA 108 (68.4%) 91 (66.4%) 17 (80.9%) 0.216 
Laminar medial collapse 75 (47.5%) 68 (49.6%) 7 (33.3%) 0.240 
Dense laminar medial collapse 59 (37.3%) 53 (38.7%) 6 (28.6%) 0.471 
Elastic fibre thinning out 145 (92.8%) 129 (94.2%) 16 (76.2%) 0.787 
Moderate/severe elastic fibre 
thinning out 
108 (68.4%) 96 (70.1%) 12 (57.1%) 0.313 
Elastic fibre fragmentation 153 (98.7%) 132 (96.3%) 21 (100%) 0.374 
Moderate/severe elastic fibre 
fragmentation 
117 (74%) 112 (81.7%) 5 (23.8%) < 0.001 
Intralamellar collagen increase 117 (74%) 104 (75.9%) 13 (61.9%) 0.187 




Translamellar collagen increase 30 (19%) 28 (20.4%) 2 (9.5%) 0.371 
Moderate-severe translamellar 
collagen increase 
18 (11.4%) 17 (12.4%) 1 (4.8%) 0.471 
Degenerative group 122 (77.2%) 102 (74.5%) 20 (95.2%) 0.047 
Mixed group 36 (22.8%) 35 (25.5%) 1 (4.8%) 0.047 
Overall severe degenerative 38 (24%) 31 (22.6%) 7 (33.3%) 0.284 
AAS: Acute Aortic Syndrome; I-MEMA: Intralamellar-Mucoid Extracellular Matrix Accumulation; 574 




















Supplementary figure 1 Specimens of type A aortic dissection. A: Dissection involves some 75% 593 
of circumference and the false lumen contains thrombosis; atherosclerotic plaques are visible in the 594 
intima (arrow). B: Aortic sample where dissection is more extensive (90% of circumference) and 595 
the aortic wall is extremely thinned. C-D: Extensive dissection and irregular intimal surface due to 596 















Supplementary figure 3 A: a severe focus of translamellar mucoid extracellular matrix 621 
accumulation in a degenerative group patient (Haematoxylin-Eosin stain, original magnification 622 
x200); B: medial fibrosis (i.e. translamellar collagen increase), a distinctive lesion of the mixed 623 
group (Azan Mallory tricrhome, original magnification x200). C-D: Laminar medial collapse. In 624 
mixed group this lesion was frequently found as a dense band of elastic fibre compaction bordering 625 
the lower margin of atherosclerotic plaques (C: arrow; Weigert Van Gieson, original magnification 626 
x100); in degenerative patients the lesion was frequently seen in the central areas of the medial 627 
layer above or on the same plane of the dissection (arrow) (Weigert Van Gieson, original 628 







Supplementary figure 4 6-year non-aorta-related events of type A AAS according to patients’ CV 634 
risk profile. High CV risk means patients with history of coronary artery disease and/or history of 635 
stroke and/or aged 40 or older with at least one CV risk factor (hypertension, hypercholesterolemia, 636 
diabetes, current smoke). 637 
638 
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